Cargando…
Recurrent, Delayed Hemorrhage Associated with Edoxaban after Deep Brain Stimulation Lead Placement
Factor-Xa inhibitors like edoxaban have been shown to have comparable or superior rates of stroke and systemic embolization prevention to warfarin while exhibiting lower clinically significant bleeding rates. The authors report a case of a man who presented with delayed, recurrent intracranial hemor...
Autores principales: | Sivakumar, Walavan, Garber, Sarah T., Schrock, Lauren E., House, Paul A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3556834/ https://www.ncbi.nlm.nih.gov/pubmed/23365773 http://dx.doi.org/10.1155/2013/691840 |
Ejemplares similares
-
Intracerebral Hemorrhage and Venous Infarction after Deep Brain Stimulation Lead Placement
por: Cui, Zhi-Qiang, et al.
Publicado: (2018) -
Delayed intracerebral hemorrhage associated with placement of a deep brain stimulating electrode over two years prior
por: Radziunas, Andrius, et al.
Publicado: (2021) -
Diffuse Alveolar Hemorrhage Associated with Edoxaban Therapy
por: Nitta, Kenichi, et al.
Publicado: (2016) -
Delayed hemorrhage following deep brain stimulation device placement in a patient with Parkinson’s disease and lupus anticoagulant syndrome: illustrative case
por: Walker, Robert B., et al.
Publicado: (2022) -
Symptomatic, left-sided deep brain stimulation lead edema 6 h after bilateral subthalamic nucleus lead placement
por: Lee, Jonathan J., et al.
Publicado: (2019)